Bio-Rad Labs (BIO) Reports Q4 EPS of $1.68
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $278.21 --0%
Revenue Growth %: -7.0%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: -7.0%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $1.68, does not compare to the analyst estimate of $1.27. Revenue for the quarter came in at $570.6 million versus the consensus estimate of $570.8 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Uxin Limited (UXIN) Tops Q3 EPS by 49c; offers outlook
- Analysts favorite fintech stock Adyen tumbles after revenue miss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
